Cargando…
Angiopoietin-1 Upregulates Cancer Cell Motility in Colorectal Cancer Liver Metastases through Actin-Related Protein 2/3
SIMPLE SUMMARY: Vessel co-option has been recognized as a mechanism associated with resistance to anti-angiogenic treatment in colorectal cancer liver metastases (CRCLMs). Recently, we reported that Angiopoietin-1 (Ang1) stimulates vessel co-option in CRCLM through an unknown mechanism. In this manu...
Autores principales: | Rada, Miran, Kapelanski-Lamoureux, Audrey, Tsamchoe, Migmar, Petrillo, Stephanie, Lazaris, Anthoula, Metrakos, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139616/ https://www.ncbi.nlm.nih.gov/pubmed/35626145 http://dx.doi.org/10.3390/cancers14102540 |
Ejemplares similares
-
Cancer Cells Promote Phenotypic Alterations in Hepatocytes at the Edge of Cancer Cell Nests to Facilitate Vessel Co-Option Establishment in Colorectal Cancer Liver Metastases
por: Rada, Miran, et al.
Publicado: (2022) -
Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases
por: Rada, Miran, et al.
Publicado: (2021) -
A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases
por: Rada, Miran, et al.
Publicado: (2023) -
Angiopoietin1 Deficiency in Hepatocytes Affects the Growth of Colorectal Cancer Liver Metastases (CRCLM)
por: Ibrahim, Nisreen S., et al.
Publicado: (2019) -
The molecular mechanisms underlying neutrophil infiltration in vessel co-opting colorectal cancer liver metastases
por: Rada, Miran, et al.
Publicado: (2022)